How to manage CVD risk in PCa patients during COVID-19
How do you manage CVD risk in PCa patients during COVID-19?
What's in store for you in Module 2?
Look forward to the following presentations by renowned experts in their respective fields:
Moderator: P-A. Abrahamsson (SE)
Impact of COVID-19 on cardio-oncology
By Prof. Arjun Ghosh (GB), cardio-oncologist
COVID-19 Recommendations for Prostate Cancer treatment by the EAU Guidelines
By Prof. Dr. Maria Ribal (ES), urologist
How to manage prostate cancer in a pandemic
By Dr. Ricardo Rendon (CA), urologic oncologist
Hormonal treatment of urological cancers during COVID-19
By Prof. Mark Linch (GB), oncologist
This online curriculum is developed by the Canadian Urological Association (CUA), the International Cardio-Oncology Society (ICOS), and the European Association of Urology (EAU) and combines quality scientific content with current evidence-based recommendations and real-life clinical practice experience.
At a glance
Publication date: April 2021
Available languages: English
Topic: Prostate cancer
CME: This webinar is accredited with 1 European CME credit (ECMEC®) upon completion of the questionnaire after attending the live webinar
Duration: Approx. 60 minutes
This educational activity has been funded by Ferring. The educational programme of this online activity has been a collaboration with Ferring, but independently developed and approved by the Canadian Urological Association, the International Cardio-Oncology Society together with the European Association of Urology.
Registration for this webinar is now closed
The recording will be available at www.uroweb.org/webinars 24 hours after the webinar has taken place.
Back to UROwebinar overview